trending Market Intelligence /marketintelligence/en/news-insights/trending/ki6eYDQsLrM7cbMCj8cR2g2 content esgSubNav
In This List

Hologic acquires 46% stake in ultrasound maker SuperSonic Imagine

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Hologic acquires 46% stake in ultrasound maker SuperSonic Imagine

Hologic Inc. acquired about 46% of French medical ultrasound company SuperSonic Imagine SA.

SuperSonic Imagine's main shareholders — Bpifrance, Andera Partners, Auriga Partners, Mérieux Participations and CDC PME Croissance — sold their 10,841,409 shares to Hologic for €1.50 apiece.

By August-end, Hologic will file a cash tender offer, followed by a squeeze-out, for all SuperSonic outstanding shares and all shares that may be issued before the closing of the tender offer at a price of €1.50 apiece. The deal will be valued at about $42 million if all outstanding warrants and options priced lower than €1.50 apiece are exercised.

The tender offer could be completed by the end of 2019, subject to clearance from French Financial Markets Authority.

Additionally, the Marlborough, Mass.-based medical device maker will provide up to $43 million to repay SuperSonic's net debt, giving it a maximum enterprise value of $85 million.

Aix-en-Provence, France-based SuperSonic also entered into a termination agreement with Kreos pursuant to which, upon payment of about €16.4 million, certain financing agreements entered into by both parties will be terminated.